Medication-Assisted Treatment for opioid use disorder
MAT is the clinical standard of care for opioid use disorder. Suboxone, methadone, Vivitrol, and naltrexone are all typically covered by Kentucky Medicaid plans and reduce overdose mortality by more than half when continued long-term.
Kentucky Medicaid plans typically cover MAT
Kentucky Medicaid plans typically cover Suboxone, Subutex, methadone, Vivitrol, and oral naltrexone for opioid use disorder. Pick your plan to see specific formulations, authorization, and pharmacy benefit details.
Aetna Better Health
View Aetna Better Health MAT coverage →Anthem Medicaid
View Anthem Medicaid MAT coverage →Humana Healthy Horizons
View Humana Healthy Horizons MAT coverage →Passport
View Passport MAT coverage →UnitedHealthcare Community Plan
View UnitedHealthcare Community Plan MAT coverage →WellCare
View WellCare MAT coverage →Medications we offer
Suboxone
Office-based daily sublingual dosing. Partial agonist with built-in misuse deterrent.
Suboxone treatment →Subutex
Used during pregnancy when the naloxone in Suboxone isn't appropriate.
Methadone
Daily on-site dosing at a federally licensed Opioid Treatment Program (OTP).
Vivitrol
Monthly injection. Requires 7-14 days opioid-free before the first dose.
Oral naltrexone
Pill form of the same medication as Vivitrol. Lower adherence than injection.
Verify your MAT coverage and start treatment
Call us or send a message — we'll discuss your situation and help you understand your treatment options.
Frequently asked questions
Will my Kentucky Medicaid plan cover MAT?
Yes. Kentucky Medicaid plans typically cover MAT for opioid use disorder. Pharmacy prior authorization may apply to specific formulations.
Which MAT is right for me?
It depends on overdose risk, prior treatment history, pregnancy status, ability to attend daily dosing (for methadone), and personal preference. A Golden Grove clinician will help you choose during the assessment.
Can I do MAT during pregnancy?
Yes. Subutex (buprenorphine alone, without naloxone) is the standard MAT for pregnant members with OUD, and is typically covered by Kentucky Medicaid plans. Methadone in an OTP is also a coverage option.
How long should I stay on MAT?
MAT is meant to be a long-term treatment for many patients. There is no clinical evidence that shorter MAT duration improves outcomes. Tapering, when appropriate, should be gradual and clinically guided.